Fenofibrate Capsule
Product Images NDC 42858-200

This is a description of a medication called Fenofibrate, which comes in the form of capsules containing 67mg of micronized Fenofibrate. The usual adult dosage is provided in the package insert for full prescribing information. The medication should not be accepted if the seal over the bottle opening is broken or missing, and it should be stored at 20° to 25°C (68° to 77°F) and protected from moisture. The medication should be dispensed in a tight, container with a child-resistant closure (as required). This medication is to be kept out of the reach of children. The medication is manufactured in Canada by Teva Canada Limited and Marketed By Rhodes Pharmaceuticals L.P. in Coventry, RI.*

This is a medication label for capsules containing 134mg of micronized fenofibrate. The recommended dosage and storage instructions are provided, including a warning not to use if the seal is broken or missing. The medication should be kept out of reach of children and dispensed in a tight, light-resistant container with a child-resistant closure. The medication is manufactured in Canada and marketed by Rhodes Pharmaceuticals in Rhode Island.*

This is a medication containing Fenofibrate (micronized) in each capsule at a dosage of 200 mg. The adult dosage information is available in the package insert. The medication should not be used if the seal over the bottle opening is broken or missing. It should be stored at room temperature and protected from moisture. The container has a child-resistant closure, and the medication should be kept out of reach of children. The medication is manufactured in Canada by Teva Canada Limited and marketed by Rhodes Pharmaceuticals L.P. The given text does not provide a useful description.*